Companies at a glance

Brandkarma
17992 Mitchell South
Suite 200
Irvine, CA 92614
Phone: 949-585-9000
www.brandkarma.org
New Business Contact: Ken Ribotsky, CEO & President, ken.r@brandkarma.org or 949-585-9000

BulletinHealthcare
11190 Sunrise Valley Drive
Reston, VA 20191
Phone: 703-483-6100
www.bulletinhealthcare.com
New Business Contact: Michael Laxineta, President, mlaxineta@bulletinheathcare.com

Flashpoint Medica
158 West 28th Street
New York, NY 10001
&
650 California Street
San Francisco, CA 94108
Phone: 917-472-2321
www.flashpointmedica.com,
@flashpointny, www.facebook.com/flashpointmedica
Email: nicole.johnson@flashpointmedica.com

GA Communication Group
Offices in Chicago and San Diego
Phone: 312-803-1900
www.gacommunication.com
New Business Contact: Joe Kuchta, CEO, jkuchta@gacommunication.com

ghg
200 Fifth Avenue
New York, NY 10010
Phone: 212-886-3000
Fax: 212-886-3097
www.ghgroup.com
New Business Contact: Erin Byrne, Chief Engagement ­Officer, ebyrne@ghgroup.com or 212-886-3000

Group DCA
800 Lanidex Plaza
3rd Floor
Parsippany, NJ 07054
Phone: 973-746-7777
www.groupdca.com
New Business Contact: Frank Saia, General Manager, frank.saia@groupdca.com or 917-258-2510

Klick Health
175 Bloor Street East
Toronto, ON Canada M4W 3R8
Phone:  416-214-4977
www.klick.com
Email: connect@klick.com

The Oncologist
318 Blackwell Street
Suite 260
Durham, NC 27701
Phone: 919-680-0011
www.TheOncologist.com
New Business Contact: Marty Murphy 3rd, 919-200-3727 or Marty3rd@TheOncologist.com

You must be a registered member of MMM to post a comment.

Email Newsletters


What does going "beyond the pill" actually mean? At MM&M's recent inaugural spring conference, audience members heard from real-world companies that are managing the organizational, technological, and promotional challenges inherent in this transition, such as partnering with health neophytes, harnessing technologies that allow deeper engagement with patients, and adopting a new commercial mindset to serve, not sell. Download here.


A wave of more effective anti-cancer drugs has set the oncology world on fire with enthusiasm. While many hail this as a new era, an equally vocal faction questions the money spent for the value gained. This medical and commercial trend report for marketers of anti-cancer modalities touches on many of the latest shifts that have expedited product launches and otherwise impacted promotion and reimbursement of these drugs. Click here.